1. γ-Tocotrienol inhibits angiogenesis of human umbilical vein endothelial cell induced by cancer cell.
- Author
-
Li Y, Sun WG, Liu HK, Qi GY, Wang Q, Sun XR, Chen BQ, and Liu JR
- Subjects
- Animals, Apoptosis, Cell Line, Tumor, Cell Movement, Cell Proliferation, Chemoprevention, Chick Embryo, Chorioallantoic Membrane blood supply, Chorioallantoic Membrane drug effects, Chromans therapeutic use, Down-Regulation, Human Umbilical Vein Endothelial Cells drug effects, Humans, Microscopy, Electron, Transmission, Neoplasms blood supply, Neoplasms metabolism, Neoplasms prevention & control, Neovascularization, Pathologic metabolism, Signal Transduction, Vascular Endothelial Growth Factor Receptor-2 metabolism, Vitamin E pharmacology, Vitamin E therapeutic use, beta Catenin genetics, beta Catenin metabolism, Angiogenesis Inhibitors pharmacology, Chromans pharmacology, Human Umbilical Vein Endothelial Cells physiology, Neovascularization, Pathologic pathology, Neovascularization, Pathologic prevention & control, Vitamin E analogs & derivatives
- Abstract
Antiangiogenic therapy mediated by food components is an established strategy for cancer chemoprevention. Growth factors play critical roles in tumor angiogenesis. A conditioned medium containing growth factors from human gastric adenocarcinoma SGC-7901 cell conditioned medium was used as an angiogenic stimulus in this study. The purpose of this study was to evaluate the inhibitory effect and possible mechanism of γ-tocotrienol on tumor angiogenesis. The results showed that γ-tocotrienol (10-40 μmol/L) significantly suppressed proliferation, migration and tube formation of human umbilical vein endothelial cells (HUVECs) induced by SGC-7901 cell conditioned medium in a dose-dependent manner. γ-Tocotrienol (800-1200 μg/egg) also inhibited new blood vessel formation on the growing chick embryo chorioallantoic membrane in a dose-dependent manner. Moreover, the inhibitory effects of γ-tocotrienol on HUVECs were correlated with inducing the apoptosis and arresting cell cycle at the G(0)/G(1) phase at a dose of 40 μmol/L γ-tocotrienol. In addition, γ-tocotrienol inhibited angiogenesis in HUVECs by down-regulation of β-catenin, cyclin D1, CD44, phospho-VEGFR-2 and MMP-9. The antiangiogenic effects of γ-tocotrienol on HUVECs may be attributable to regulation of Wnt signaling by decreasing β-catenin expression. Thus, our results suggest that γ-tocotrienol has a potential chemopreventive agent via antiangiogenesis., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF